Finland· FI-REL-REL50143
Biocom P Vet
A minkin enteriittivirus - / parvovirus - + inaktivoitu klostridirokote + inaktivoitu pseudomonas -rok product containing clostridium botulinum type c toxoid + mink enteritis virus type i, inactivated + mink enteritis virus type ii, inactivated + pseudomonas aeruginosa -bacteria, serotype 5, inactivated + 2 more, registered in Finland by United Vaccines Holding B.V.. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Clostridium botulinum type c toxoid + mink enteritis virus type i, inactivated + mink enteritis virus type ii, inactivated + pseudomonas aeruginosa -bacteria, serotype 5, inactivated + 2 more is registered in 2 of 19 countries.
Countries holding a registration under ATC QI20CL01 (minkin enteriittivirus - / parvovirus - + inaktivoitu klostridirokote + inaktivoitu pseudomonas -rok), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 1 of them publish a price we can compare per daily dose
Clostridium botulinum type c toxoid + mink enteritis virus type i, inactivated + mink enteritis virus type ii, inactivated + pseudomonas aeruginosa -bacteria, serotype 5, inactivated + 2 more · ATC QI20CL01
2 / 19 countries
- Denmark
- Finlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Clostridium botulinum type C toxoid + Mink enteritis virus type I, inactivated + Mink enteritis virus type II, inactivated + Pseudomonas aeruginosa -bacteria, Serotype 5, inactivated + 2 more
- Manufacturer
- United Vaccines Holding B.V.
- Country
- Finland (FI)
- ATC code
- QI20CL01
- ATC class
- Minkin enteriittivirus - / parvovirus - + Inaktivoitu Klostridirokote + Inaktivoitu Pseudomonas -rok
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under QI20CL01
Minkin enteriittivirus - / parvovirus - + inaktivoitu klostridirokote + inaktivoitu pseudomonas -rok, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/474472f5-069a-4160-8f5a-239020635e75 GET /v1/drugs/474472f5-069a-4160-8f5a-239020635e75?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, suspensio",
"route": "Ihon alle",
"ddd_unit": null,
"strength": null,
"atc_label": "Minkin enteriittivirus - / parvovirus - + Inaktivoitu Klostridirokote + Inaktivoitu Pseudomonas -rok",
"ma_number": "34710",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL50143",
"authorised_at": "2018-03-07"
}See everything about clostridium botulinum type c toxoid + mink enteritis virus type i, inactivated + mink enteritis virus type ii, inactivated + pseudomonas aeruginosa -bacteria, serotype 5, inactivated + 2 more.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.